Bioimpedance-assessed muscle wasting and its relation to nutritional intake during the first week of ICU: a pre-planned secondary analysis of Nutriti Study.
Bioimpedance analysis
Caloric debt
Critically ill patient
ICU acquired weakness
Muscle wasting
Nutrition
Proteins
Journal
Annals of intensive care
ISSN: 2110-5820
Titre abrégé: Ann Intensive Care
Pays: Germany
ID NLM: 101562873
Informations de publication
Date de publication:
17 Feb 2024
17 Feb 2024
Historique:
received:
25
11
2023
accepted:
12
02
2024
medline:
17
2
2024
pubmed:
17
2
2024
entrez:
17
2
2024
Statut:
epublish
Résumé
Muscle mass evaluation in ICU is crucial since its loss is related with long term complications, including physical impairment. However, quantifying muscle wasting with available bedside tools (ultrasound and bioimpedance analysis) must be more primarily understood. Bioimpedance analysis (BIA) provides estimates of muscle mass and phase angle (PA). The primary aim of this study was to evaluate muscle mass changes with bioimpedance analysis during the first 7 days after ICU admission. Secondary aims searched for correlations between muscular loss and caloric and protein debt. Patients with an expected ICU-stay ≥ 72 h and the need for artificial nutritional support were evaluated for study inclusion. BIA evaluation of muscle mass and phase angle were performed at ICU admission and after 7 days. Considering the difference between ideal caloric and protein targets, with adequate nutritional macronutrients delivered, we calculated the caloric and protein debt. We analyzed the potential correlation between caloric and protein debt and changes in muscle mass and phase angle. 72 patients from September 1st to October 30th, 2019 and from August 1st to October 30th, 2021 were included in the final statistical analysis. Median age was 68 [59-77] years, mainly men (72%) admitted due to respiratory failure (25%), and requiring invasive mechanical ventilation for 7 [4-10] days. Median ICU stay was 8 [6-12] days. Bioimpedance data at ICU admission and after 7 days showed that MM and PA resulted significantly reduced after 7 days of critically illness, 34.3 kg vs 30.6 kg (p < 0.0001) and 4.90° vs 4.35° (p = 0.0004) respectively. Mean muscle loss was 3.84 ± 6.7 kg, accounting for 8.4% [1-14] MM reduction. Correlation between caloric debt (r = 0.14, p = 0.13) and protein debt (r = 0.18, p = 0.13) with change in MM was absent. Similarly, no correlation was found between caloric debt (r = -0.057, p = 0.631) and protein debt (r = -0.095, p = 0.424) with changes in PA. bioimpedance analysis demonstrated that muscle mass and phase angle were significantly lower after 7 days in ICU. The total amount of calories and proteins does not correlate with changes in muscle mass and phase angle.
Sections du résumé
BACKGROUND
BACKGROUND
Muscle mass evaluation in ICU is crucial since its loss is related with long term complications, including physical impairment. However, quantifying muscle wasting with available bedside tools (ultrasound and bioimpedance analysis) must be more primarily understood. Bioimpedance analysis (BIA) provides estimates of muscle mass and phase angle (PA). The primary aim of this study was to evaluate muscle mass changes with bioimpedance analysis during the first 7 days after ICU admission. Secondary aims searched for correlations between muscular loss and caloric and protein debt.
METHODS
METHODS
Patients with an expected ICU-stay ≥ 72 h and the need for artificial nutritional support were evaluated for study inclusion. BIA evaluation of muscle mass and phase angle were performed at ICU admission and after 7 days. Considering the difference between ideal caloric and protein targets, with adequate nutritional macronutrients delivered, we calculated the caloric and protein debt. We analyzed the potential correlation between caloric and protein debt and changes in muscle mass and phase angle.
RESULTS
RESULTS
72 patients from September 1st to October 30th, 2019 and from August 1st to October 30th, 2021 were included in the final statistical analysis. Median age was 68 [59-77] years, mainly men (72%) admitted due to respiratory failure (25%), and requiring invasive mechanical ventilation for 7 [4-10] days. Median ICU stay was 8 [6-12] days. Bioimpedance data at ICU admission and after 7 days showed that MM and PA resulted significantly reduced after 7 days of critically illness, 34.3 kg vs 30.6 kg (p < 0.0001) and 4.90° vs 4.35° (p = 0.0004) respectively. Mean muscle loss was 3.84 ± 6.7 kg, accounting for 8.4% [1-14] MM reduction. Correlation between caloric debt (r = 0.14, p = 0.13) and protein debt (r = 0.18, p = 0.13) with change in MM was absent. Similarly, no correlation was found between caloric debt (r = -0.057, p = 0.631) and protein debt (r = -0.095, p = 0.424) with changes in PA.
CONCLUSIONS
CONCLUSIONS
bioimpedance analysis demonstrated that muscle mass and phase angle were significantly lower after 7 days in ICU. The total amount of calories and proteins does not correlate with changes in muscle mass and phase angle.
Identifiants
pubmed: 38367198
doi: 10.1186/s13613-024-01262-w
pii: 10.1186/s13613-024-01262-w
doi:
Types de publication
Journal Article
Langues
eng
Pagination
29Informations de copyright
© 2024. The Author(s).
Références
Boonen E, Van den Berghe G. Endocrine responses to critical illness: novel insights and therapeutic implications. J Clin Endocrinol Metab. 2014;99(5):1569–82. https://doi.org/10.1210/jc.2013-4115 .
doi: 10.1210/jc.2013-4115
pubmed: 24517153
Preiser JC, Ichai C, Orban JC, Groeneveld AB. Metabolic response to the stress of critical illness. Br J Anaesth. 2014;113(6):945–54. https://doi.org/10.1093/bja/aeu187 .
doi: 10.1093/bja/aeu187
pubmed: 24970271
Hamill RW, Woolf PD, McDonald JV, Lee LA, Kelly M. Catecholamines predict outcome in traumatic brain injury. Ann Neurol. 1987;21:438–43.
doi: 10.1002/ana.410210504
pubmed: 3592639
Iapichino G, Radrizzani D, Armani S, Noto A, Spanu P, Mistraletti G. Metabolic treatment of critically ill patients: energy balance and substrate disposal. Minerva Anestesiol. 2006;72:533–41.
pubmed: 16682927
Gamrin-Gripenberg L, Sundström-Rehal M, Olsson D, Grip J, Wernerman J, Rooyackers O. An attenuated rate of leg muscle protein depletion and leg free amino acid efflux over time is seen in ICU long-stayers. Crit Care. 2018;22(1):13. https://doi.org/10.1186/s13054-017-1932-6 .
doi: 10.1186/s13054-017-1932-6
pubmed: 29361961
pmcid: 5782367
Puthucheary ZA, Rawal J, McPhail M, Connolly B, Ratnayake G, Chan P, et al. Acute skeletal muscle wasting in critical illness. JAMA. 2013;310(15):1591–600. https://doi.org/10.1001/jama.2013.278481 .
doi: 10.1001/jama.2013.278481
pubmed: 24108501
Wandrag L, Brett SJ, Frost GS, Bountziouka V, Hickson M. Exploration of muscle loss and metabolic state during prolonged critical illness: Implications for intervention? PLoS ONE. 2019;14(11): e0224565. https://doi.org/10.1371/journal.pone.0224565 .
doi: 10.1371/journal.pone.0224565
pubmed: 31725748
pmcid: 6855435
Vanhorebeek I, Latronico N, Van den Berghe G. ICU-acquired weakness. Intensive Care Med. 2020;46(4):637–53. https://doi.org/10.1007/s00134-020-05944-4 .
doi: 10.1007/s00134-020-05944-4
pubmed: 32076765
pmcid: 7224132
De Rosa S, Umbrello M, Pelosi P, Battaglini D. Update on lean body mass diagnostic assessment in critical illness. Diagnostics. 2023;13(5):888. https://doi.org/10.3390/diagnostics13050888 .
doi: 10.3390/diagnostics13050888
pubmed: 36900032
pmcid: 10000858
Paris MT, Lafleur B, Dubin JA, Mourtzakis M. Development of a bedside viable ultrasound protocol to quantify appendicular lean tissue mass. J Cachexia Sarcopenia Muscle. 2017;8(5):713–26. https://doi.org/10.1002/jcsm.12213 .
doi: 10.1002/jcsm.12213
pubmed: 28722298
pmcid: 5659058
Formenti P, Umbrello M, Coppola S, Froio S, Chiumello D. Clinical review: peripheral muscular ultrasound in the ICU. Ann Intensive Care. 2019;9(1):57. https://doi.org/10.1186/s13613-019-0531-x .
doi: 10.1186/s13613-019-0531-x
pubmed: 31101987
pmcid: 6525229
Mourtzakis M, Parry S, Connolly B, Puthucheary Z. Skeletal muscle ultrasound in critical care: a tool in need of translation. Ann Am Thorac Soc. 2017;14(10):1495–503. https://doi.org/10.1513/AnnalsATS.201612-967PS .
doi: 10.1513/AnnalsATS.201612-967PS
pubmed: 28820608
pmcid: 5718569
Curz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16–31.
doi: 10.1093/ageing/afy169
Danielis M, Mattiussi E, Piani T, Iacobucci A, Tullio A, Molfino A, Nutriti Study Group, et al. Diarrhoea and constipation during artificial nutrition in intensive care unit: a prospective observational study. Clin Nutr ESPEN. 2023;57:375–80. https://doi.org/10.1016/j.clnesp.2023.07.007 .
doi: 10.1016/j.clnesp.2023.07.007
pubmed: 37739681
Deana C, Rovida S, Orso D, Bove T, Bassi F, De Monte A, et al. Learning from the Italian experience during COVID-19 pandemic waves: be prepared and mind some crucial aspects. Acta Biomed. 2021;92(2): e2021097. https://doi.org/10.23750/abm.v92i2.11159 .
doi: 10.23750/abm.v92i2.11159
pubmed: 33988143
pmcid: 8182622
Moonen HPFX, Van Zanten ARH. Bioelectric impedance analysis for body composition measurement and other potential clinical applications in critical illness. Curr Opin Crit Care. 2021;27(4):344–53. https://doi.org/10.1097/MCC.0000000000000840 .
doi: 10.1097/MCC.0000000000000840
pubmed: 33967207
pmcid: 8270506
Mulasi U, Kuchnia AJ, Cole AJ, Earthman CP. Bioimpedance at the bedside: current applications, limitations, and opportunities. Nutr Clin Pract. 2015;30(2):180–93. https://doi.org/10.1177/0884533614568155 .
doi: 10.1177/0884533614568155
pubmed: 25613832
Lukaski HC. Evolution of bioimpedance: a circuitous journey from estimation of physiological function to assessment of body composition and a return to clinical research. Eur J Clin Nutr. 2013;67(suppl 1):S2–9.
doi: 10.1038/ejcn.2012.149
pubmed: 23299867
Myatchin I, Abraham P, Malbrain MLNG. Bio-electrical impedance analysis in critically ill patients: are we ready for prime time? J Clin Monit Comput. 2020;34(3):401–10. https://doi.org/10.1007/s10877-019-00439-0 .
doi: 10.1007/s10877-019-00439-0
pubmed: 31808061
Lukaski HC, Bolonchuk WW, Hall CB, Siders WA. Validation of tetrapolar bioelectrical impedance method to assess human body composition. J Appl Physiol. 1986;60(4):1327–32. https://doi.org/10.1152/jappl.1986.60.4.1327 .
doi: 10.1152/jappl.1986.60.4.1327
pubmed: 3700310
Bioelectrical Impedance Analysis in Body Composition Measurement. Proceedings of a National Institutes of Health Technology Assessment Conference. Bethesda, Maryland, December 12-14, 1994. Am J Clin Nutr. 1996;64(3 Suppl):387S-532S. https://doi.org/10.1093/ajcn/64.3.387S .
doi: 10.1093/ajcn/64.3.387S
Singer P, Blaser AR, Berger MM, Alhazzani W, Calder PC, Casaer MP, et al. ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutr. 2019;38(1):48–79. https://doi.org/10.1016/j.clnu.2018.08.037 .
doi: 10.1016/j.clnu.2018.08.037
pubmed: 30348463
Deana C, Vetrugno L, Cortegiani A, Mongodi S, Salve G, Mangiagalli M, et al. On behalf of the Italian Odissea group quality of life in COVID-related ards patients one year after intensive care discharge (Odissea Study): a Multicenter Observational Study. J Clin Med. 2023;12(3):1058. https://doi.org/10.3390/jcm12031058 .
doi: 10.3390/jcm12031058
pubmed: 36769705
pmcid: 9918008
Herridge MS, Tansey CM, Matté A, Tomlinson G, Diaz-Granados N, Cooper A, et al. Canadian Critical Care Trials Group. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med. 2011;364(14):1293–304. https://doi.org/10.1056/NEJMoa1011802 .
doi: 10.1056/NEJMoa1011802
pubmed: 21470008
Lopez-Ruiz A, Kashani K. Assessment of muscle mass in critically ill patients: role of the sarcopenia index and images studies. Curr Opin Clin Nutr Metab Care. 2020;23(5):302–11. https://doi.org/10.1097/MCO.0000000000000673 .
doi: 10.1097/MCO.0000000000000673
pubmed: 32657790
Fazzini B, Märkl T, Costas C, Blobner M, Schaller SJ, Prowle J, et al. The rate and assessment of muscle wasting during critical illness: a systematic review and meta-analysis. Crit Care. 2023;27(1):2. https://doi.org/10.1186/s13054-022-04253-0 .
doi: 10.1186/s13054-022-04253-0
pubmed: 36597123
pmcid: 9808763
Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Manuel Gómez J, et al. ESPEN. Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr. 2004;23(6):1430–53. https://doi.org/10.1016/j.clnu.2004.09.012 .
doi: 10.1016/j.clnu.2004.09.012
pubmed: 15556267
Forni LG, Hasslacher J, Joannidis M. Bioelectrical impedance vector analysis in the critically ill: cool tool or just another ‘toy’? Crit Care. 2015;11(19):387. https://doi.org/10.1186/s13054-015-1110-7 .
doi: 10.1186/s13054-015-1110-7
Kim D, Sun JS, Lee YH, Lee JH, Hong J, Lee JM. Comparative assessment of skeletal muscle mass using computerized tomography and bioelectrical impedance analysis in critically ill patients. Clin Nutr. 2019;38(6):2747–55. https://doi.org/10.1016/j.clnu.2018.12.002 .
doi: 10.1016/j.clnu.2018.12.002
pubmed: 30612851
Looijaard WGPM, Stapel SN, Dekker IM, Rusticus H, Remmelzwaal S, Girbes ARJ, et al. Identifying critically ill patients with low muscle mass: agreement between bioelectrical impedance analysis and computed tomography. Clin Nutr. 2020;39(6):1809–17. https://doi.org/10.1016/j.clnu.2019.07.020 .
doi: 10.1016/j.clnu.2019.07.020
pubmed: 31492456
Norman K, Stobäus N, Pirlich M, Bosy-Westphal A. Bioelectrical phase angle and impedance vector analysis–clinical relevance and applicability of impedance parameters. Clin Nutr. 2012;31(6):854–61. https://doi.org/10.1016/j.clnu.2012.05.008 .
doi: 10.1016/j.clnu.2012.05.008
pubmed: 22698802
Formenti P, Coppola S, Umbrello M, Froio S, Caccioppola A, De Giorgis V, et al. Time course of the bioelectrical impedance vector analysis and muscular ultrasound in critically ill patients. J Crit Care. 2022;68:89–95. https://doi.org/10.1016/j.jcrc.2021.11.014 .
doi: 10.1016/j.jcrc.2021.11.014
pubmed: 34952476
Weijs PJ, Looijaard WG, Beishuizen A, Girbes AR, Oudemans-van Straaten HM. Early high protein intake is associated with low mortality and energy overfeeding with high mortality in non-septic mechanically ventilated critically ill patients. Crit Care. 2014;18(6):701. https://doi.org/10.1186/s13054-014-0701-z .
doi: 10.1186/s13054-014-0701-z
pubmed: 25499096
pmcid: 4279460
Heyland DK, Patel J, Compher C, Rice TW, Bear DE, Lee ZY, et al. EFFORT protein trial team the effect of higher protein dosing in critically ill patients with high nutritional risk (EFFORT Protein): an international, multicentre, pragmatic, registry-based randomised trial. Lancet. 2023;401(10376):568–76. https://doi.org/10.1016/S0140-6736(22)02469-2 .
doi: 10.1016/S0140-6736(22)02469-2
pubmed: 36708732
Casaer MP, Mesotten D, Hermans G, Wouters PJ, Schetz M, Meyfroidt G, et al. Early versus late parenteral nutrition in critically ill adults. N Engl J Med. 2011;365(6):506–17. https://doi.org/10.1056/NEJMoa1102662 .
doi: 10.1056/NEJMoa1102662
pubmed: 21714640
Reignier J, Plantefeve G, Mira JP, Argaud L, Asfar P, Aissaoui N, et al. NUTRIREA-3 Trial Investigators; Clinical Research in Intensive Care; Sepsis (CRICS-TRIGGERSEP)Group. Low versus standard calorie and protein feeding in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group trial (NUTRIREA-3). Lancet Respir Med. 2023. https://doi.org/10.1016/S2213-2600(23)00092-9 .
doi: 10.1016/S2213-2600(23)00092-9
pubmed: 37244267
Fivez T, Kerklaan D, Mesotten D, Verbruggen S, Wouters PJ, Vanhorebeek I, et al. Early versus Late Parenteral Nutrition in Critically Ill Children. N Engl J Med. 2016;374(12):1111–22. https://doi.org/10.1056/NEJMoa1514762 . (Epub 2016 Mar 15).
doi: 10.1056/NEJMoa1514762
pubmed: 26975590
Jan G, Ilse V, Thiessen Steven E, Van den Berghe G. Amino acid supplements in critically ill patients. Pharmacol Res. 2018. https://doi.org/10.1016/j.phrs.2017.12.007 .
doi: 10.1016/j.phrs.2017.12.007
Casaer MP, Langouche L, Coudyzer W, Vanbeckevoort D, De Dobbelaer B, Güiza FG, et al. Impact of early parenteral nutrition on muscle and adipose tissue compartments during critical illness. Crit Care Med. 2013;41(10):2298–309. https://doi.org/10.1097/CCM.0b013e31828cef02 .
doi: 10.1097/CCM.0b013e31828cef02
pubmed: 23860247
Hermans G, Casaer MP, Clerckx B, Güiza F, Vanhullebusch T, Derde S, et al. Effect of tolerating macronutrient deficit on the development of intensive-care unit acquired weakness: a subanalysis of the EPaNIC trial. Lancet Respir Med. 2013;1(8):621–9. https://doi.org/10.1016/S2213-2600(13)70183-8 .
doi: 10.1016/S2213-2600(13)70183-8
pubmed: 24461665
Casaer MP, Wilmer A, Hermans G, Wouters PJ, Mesotten D, Van den Berghe G. Role of disease and macronutrient dose in the randomized controlled EPaNIC trial: a post hoc analysis. Am J Respir Crit Care Med. 2013;187(3):247–55. https://doi.org/10.1164/rccm.201206-0999OC .
doi: 10.1164/rccm.201206-0999OC
pubmed: 23204255
Gunst J. Recovery from critical illness-induced organ failure: the role of autophagy. Crit Care. 2017;21(1):209. https://doi.org/10.1186/s13054-017-1786-y .
doi: 10.1186/s13054-017-1786-y
pubmed: 28784175
pmcid: 5547478
Stoppe C, Patel JJ, Zarbock A, Lee ZY, Rice TW, Mafrici B, et al. The impact of higher protein dosing on outcomes in critically ill patients with acute kidney injury: a post hoc analysis of the EFFORT protein trial. Crit Care. 2023;27(1):399. https://doi.org/10.1186/s13054-023-04663-8 .
doi: 10.1186/s13054-023-04663-8
pubmed: 37853490
pmcid: 10585921
Thibault R, Makhlouf AM, Mulliez A, Cristina Gonzalez M, Kekstas G, Kozjek NR, et al. Phase Angle Project Investigators. Fat-free mass at admission predicts 28-day mortality in intensive care unit patients: the international prospective observational study Phase Angle Project. Intensive Care Med. 2016;42(9):1445–53. https://doi.org/10.1007/s00134-016-4468-3 .
doi: 10.1007/s00134-016-4468-3
pubmed: 27515162
Dorward DA, Russell CD, Um IH, Elshani M, Armstrong SD, Penrice-Randal R, et al. Tissue-specific immunopathology in fatal COVID-19. Am J Respir Crit Care Med. 2021;203(2):192–201. https://doi.org/10.1164/rccm.202008-3265OC .
doi: 10.1164/rccm.202008-3265OC
pubmed: 33217246
pmcid: 7874430
Umbrello M, Guglielmetti L, Formenti P, Antonucci E, Cereghini S, Filardo C, et al. Qualitative and quantitative muscle ultrasound changes in patients with COVID-19-related ARDS. Nutrition. 2021;91:111449. https://doi.org/10.1016/j.nut.2021.111449 .
doi: 10.1016/j.nut.2021.111449
pubmed: 34583135
pmcid: 8364677
Callahan LA, Supinski GS. Sepsis-induced myopathy. Crit Care Med. 2009;37(10 Suppl):S354–67. https://doi.org/10.1097/CCM.0b013e3181b6e439 .
doi: 10.1097/CCM.0b013e3181b6e439
pubmed: 20046121
pmcid: 3967515